Emma Betuel

The Latest from Emma Betuel

UK-based mental health provider ieso raises $53M armed with an ‘unprecedented’ data set

U.K.-based digital therapy company ieso announced a $53 million Series B round on Tuesday. The round is the funding the company needs to move in a brand new direction: creating more intuitive autonomo

Generate Biomedicines raises $370M Series B with a focus on protein-based drugs

The drug development space is continuing to attract more and more investment. On Thursday, another major player, Generate Biomedicines, announced a $370 million Series B round.  Generate Biomedicines

EasyHealth, a startup targeting the Medicare experience, announces $135M Series A

EasyHealth, a startup focused on navigating the Medicare experience, announced a $135 million Series A round on Thursday. EasyHealth has a simple purpose: to help enroll, and follow-up with (more on t

H1 closes $100M Series C on the back of ‘incredible traction’ and a successful first use case

Fresh off of a $58 million Series B round, and just one year after graduating from Y combinator, H1, a “LinkedIn for the healthcare industry” has raised even more cash. On Tuesday, the company ann

Nirvana Health announces $7.5M seed extension to help therapists navigate a ‘new world’ of insurance

As funding pours into mental health tech, one thing remains relatively unchanged: complex insurance billing. Now, even that medieval process is starting to attract startup interest — from compan

Trialjectory on track to match 50K cancer patients with clinical trials this year: 35% are from underrepresented groups

Each year millions of people are diagnosed with cancer. Meanwhile, hundreds of clinical trials testing potential treatments are ongoing. But there’s a gap between the people who need treatment and t

Frequency Therapeutics redesigns study after disappointing Phase 2 results, debuts new hearing loss and MS drugs

In Frequency Therapeutics’ short lifetime as a company, it’s had its ups and downs. On Tuesday, during an R&D event day, the company unleashed a slew of announcements that add context to the d

Flagship Pioneering’s new venture is betting on tRNA to treat ‘thousands of diseases’

On Tuesday, Flagship Pioneering, the major investor behind Moderna, announced yet another addition to their portfolio of RNA-curious companies. Following a year of hype around mRNA, a new company, cal

Immunai announces a $215M Series B as its ‘immune cell atlas’ matures

Biotech startup Immunai has been on a roll when it comes to funding. The company that set out to create an atlas of the human immune system in 2018 had raised about $80 million by February 2021. On We

Anomaly announces $17M in funding to tackle a $300B healthcare problem

Anomaly, a company looking to simplify medical billing, announced a $12 million Series A round on Tuesday. Anomaly is a young company — it was only founded in 2020. But it has its eye set on an

UK startup Healx to begin clinical trial on repositioned drug for Fragile X syndrome

There are currently no approved cures for Fragile X syndrome — the most common cause of inherited intellectual disability. At the moment, the treatments are designed to manage symptoms, from anx

Overwatch Research closes $3.5 million seed round to tackle a foundational preclinical research problem

Overwatch Research, a company creating workflow software for medical research, announced a $3.5 million seed round on Tuesday. This round of funding will help Overwatch expand its presence into the U.

Limbix releases clinical trial data on a self-guided mental health app for teens

In October, Limbix, a company creating digital therapeutics for adolescents, released data from a trial on its new product: SparkRx. SparkRx is a self-guided therapy program for teens run entirely on

NFX-backed Pepper Bio Emerges from stealth with tools to hone in on complex diseases

There’s a clear pain point when it comes to drug discovery: Depending on which study you cite, creating an approved drug costs anywhere from $985 million to $2.6 billion. And R&D returns have re

SkyCell raises a $35 million series C round and enters COVID-19 vaccine distribution market

SkyCell, a Swiss company developing smart containers for transporting medicines and vaccines, is announcing a significant round of funding. On top of a $62 million round that closed last year, the com

IsoPlexis, a company uncovering a ‘new layer’ of cell data, aims for $125M in market debut

Shares of IsoPlexis, a company creating tools to zoom in on the flurry of protein activity surrounding a single cell, began trading on Friday. The company aims to raise about $125 million with the IPO

GraphWear closes $20.5M Series B for a needle-free, nanotech-powered glucose monitor

GraphWear, a company pursuing needle-free approaches to glucose monitoring, has closed a $20.5 million Series B round. This Series B round is a vote of confidence by investors in GraphWear’s approac

How four-person startup Luminopia is using TV to treat lazy eye 

If you’re diagnosed with lazy eye — otherwise known as amblyopia — as a child, there are only a few options at your disposal. You can wear an eye patch, you can take eye drops or you can

Activ Surgical raises $45 million Series B round to give surgeons eagle eyes

Activ Surgical, a Boston-based digital surgery company, announced a $45 million Series B round on Thursday. The round comes during a critical year for Activ Surgical. It’s in the process of developi

The Blue Box is betting on the future of at-home breast cancer tests

You can take a pregnancy test or colon cancer test from your bathroom, or, these days, a COVID-19 test from the comfort of your living room. You might one day be able to get a breast cancer screening
Load More